$EWTX
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Healthcare
Sector
Biotechnology
Industry
Kevin Koch
CEO
117
Employees
$33.33
Current Price
$2.90B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 4 | $2,118,138.15 | 66,358 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 4 | $2,118,138.15 | 66,358 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 9 | $5,517,604.39 | 181,829 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Donovan Joanne M. CMO | Sale | 28,662 | $32.31 | $926,095.02 | View Details |
| Mar 31, 2026 | Donovan Joanne M. CMO | Sale | 21,338 | $32.12 | $685,308.28 | View Details |
| Mar 27, 2026 | Donovan Joanne M. CMO | Sale | 9,623 | $30.98 | $298,099.37 | View Details |
| Mar 27, 2026 | Donovan Joanne M. CMO | Sale | 6,735 | $30.98 | $208,635.48 | View Details |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 13,690 | $29.44 | $403,033.60 | View Details |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 66,477 | $29.44 | $1,957,082.88 | View Details |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 17,236 | $29.44 | $507,427.84 | View Details |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 7,605 | $29.44 | $223,891.20 | View Details |
| Jan 21, 2026 | Edris Badreddin Director | Sale | 10,463 | $29.44 | $308,030.72 | View Details |
15 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated-$0.43
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: